2025 Cellular Immune Tolerance Symposium

Date & Location
Thursday, May 1, 2025, 7:30 AM – Friday, May 2, 2025, 4:20 PM, Li Ka Shing Center for Learning and Knowledge (LKSC), Stanford, CA
Overview
The Stanford Cellular Immune Tolerance educational symposium is a two day event that will highlight cutting-edge research and clinical studies of cellular therapy interventions for transplantation and autoimmunity. The symposium will provide participants with updated information about different cell therapy strategies including hematopoietic stem cell transplantation, T regulatory cell therapy, dendritic cell therapy and modifying tissues for immune evasion. The review will utilize a variety of learning modalities including didactics, panel discussion and audience response questions, to facilitate meaningful interactions between expert faculty presenters and symposium participants.
Registration
In Person | Physician & Allied Health – $125.00
In Person | Industry – $300.00
In Person |Trainees (Post Docs, Fellows, Residents & Medical Students: $50.00
In Person|Stanford Medicine (SOM, SHC, SCH) staff (must use Stanford email to register): $0.00
Virtual | Physician & Allied Health – $75.00
Virtual | Industry – $300.00
Virtual | Trainees (Post Docs, Fellows, Residents & Medical Students: $25.00
Virtual| Stanford Medicine (SOM, SHC, SCH) staff (must use Stanford email to register): $0.00
**A profile must be completed when registering for the course even if not planning to claim CME.
Credits
AMA PRA Category 1 Credits™ (12.50 hours), ABIM MOC Part 2 (12.50 hours), ANCC Contact Hours (12.50 hours), CA BRN – California Board of Registered Nurses Contact Hours (12.50 hours)
Target Audience
Specialties – Allergy & Immunology, Endocrinology, Diabetes, & Metabolism, Hematology, Internal Medicine, Nephrology, Neurology , Rheumatology, Surgery
Professions – Fellow/Resident, Non-Physician, Physician, Student
Objectives
At the conclusion of this activity, learners should be able to:
Identify and contextualize key cellular therapy treatment strategies that are in clinical practice or under clinical trial investigation for transplantation and/or the treatment of autoimmune diseases such hematopoietic stem cell transplantation, T regulatory cell therapy and others. Assess the data to support the use of autologous hematopoietic stem cell transplantation for the treatment of scleroderma and multiple sclerosis. Evaluate the clinical trial investigation and implementation of genetically modified T regulatory cells for use in the prevention or treatment of transplantation rejection and autoimmunity such as Type 1 diabetes or rheumatoid arthritis Discuss how the development of cellular immune tolerance may shape the implementation of stem cell and regenerative medicine therapeutics.
Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this Live Activity for a maximum of 12.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Stanford Medicine designates this live activity for a maximum of 12.50 ANCC contact hours.
California Board of Registered Nursing (CA BRN)
Stanford Medicine Provider approved by the California Board of Registered Nursing, Provider Number 17874, forc12.50 contact hours.

American Board of Internal Medicine MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MOC Participation Threshold
Learner writes a reflective statement and makes a commitment to change or maintain an element of practice. Validity of all written statements will be assessed prior to awarding credit.